المؤلفون: Simona de Portu, Sabato Montella, Paolo Cortesi, Enrica Menditto, Simona Cammarota, Anna Citarella, Lorenzo G. Mantovani

المصدر: Farmeconomia: Health Economics and Therapeutic Pathways, Vol 12, Iss 2S, Pp 41-52 (2011)

مصطلحات موضوعية: cost-effectiveness, atorvastatin, avert trial, ideal trial, miracl trial, prove-it trial, tnt trial, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://journals.seedmedicalpublishers.com/index.php/FE/article/view/995; https://doaj.org/toc/2240-256X

URL الوصول: https://doaj.org/article/b210c461bf7a4ca982d18567a0dc9f8b

المؤلفون: Lorenzo G. Mantovani, Paolo Cortesi, Enrica Menditto, Simona de Portu, Simona Cammarota, Sabato Montella, Anna Citarella

المصدر: Farmeconomia: Health Economics and Therapeutic Pathways, Vol 12, Iss 2S, Pp 41-52 (2011)
Farmeconomia. Health economics and therapeutic pathways; Vol 12, No 2S (2011); 41-52

مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, Atorvastatin, Psychological intervention, MIRACL, Indirect costs, Pharmacoeconomics, Health economics, medicine, Cost-effectiveness, AVERT trial, IDEAL trial, MIRACL trial, PROVE-IT trial, TNT trial, Intensive care medicine, avert trial, cost-effectiveness, lcsh:R5-920, business.industry, atorvastatin, Economic benefits, Surgery, Tolerability, Simvastatin, lipids (amino acids, peptides, and proteins), tnt trial, ideal trial, business, lcsh:Medicine (General), miracl trial, prove-it trial, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fffe9d10ae59d894f3289c7292c569a3
https://journals.seedmedicalpublishers.com/index.php/FE/article/view/995